Patricia Hurter

Patricia Hurter is the CEO and a Board Member at Lyndra Therapeutics. She is also a Board Member at Synlogic, Inc. and formerly the Senior Vice President of Pharmaceutical & Preclinical Sciences at Vertex Pharmaceuticals.

Patricia holds a PhD in Chemical Engineering from Massachusetts Institute of Technology.